Sanofi and Harris Poll global hemophilia study finds ‘troubling disconnect’ between patients and providersnews2023-10-11T18:21:17+00:00October 11th, 2023|Endpoints News|
Moderna’s new Covid-19 vaccine analysis ‘giving weight’ to annual boosting interval, company saysnews2023-10-11T18:13:49+00:00October 11th, 2023|Endpoints News|
Humana CEO Bruce Broussard is stepping down next yearnews2023-10-11T18:02:52+00:00October 11th, 2023|Endpoints News|
Walgreens hires longtime Cigna executive Tim Wentworth as CEOnews2023-10-11T17:42:29+00:00October 11th, 2023|Endpoints News|
CRO at center of Pfizer’s Lyme vaccine study woes says FDA found no trial misconduct news2023-10-11T17:10:54+00:00October 11th, 2023|Endpoints News|
FDA launches new digital health adcomm to tackle incoming complexitiesnews2023-10-11T16:28:04+00:00October 11th, 2023|Endpoints News|
FDA hits New Jersey API manufacturer with 14 deficiencies across three sites in Form 483news2023-10-11T16:08:33+00:00October 11th, 2023|Endpoints News|
eGenesis brings kidney xenotransplants closer to the clinicnews2023-10-11T15:18:30+00:00October 11th, 2023|Endpoints News|
Microbiome startup sells off assets; Faron’s PhI/II data in bone marrow cancer; AM Pharma touts biomarker resultsnews2023-10-11T14:38:58+00:00October 11th, 2023|Endpoints News|
MC2 Therapeutics gears up for Phase IIb hidradenitis suppurativa trial following early clinical resultsnews2023-10-11T12:15:37+00:00October 11th, 2023|Endpoints News|
